The malaria drug is quickly falling out of favor with the medical community as a potential treatment for the disease. On the back of mounting concerns about hydroxychloroquine's safety, global pharmaceutical major Sanofi (NASDAQ:SNY) has quit providing it to COVID-19 patients enrolled in its clinical trials for the drug. It has also put a temporary…
A box of Plaquenil, an anti-malaria drug hydroxychloroquine made by Sanofi, used for years to treat malaria and autoimmune disorders.Alain Pitton | NurPhoto | Getty ImagesFrench drugmaker Sanofi said Friday it is suspending recruitment of new patients for its clinical trials looking at anti-malaria drug hydroxychloroquine as a potential treatment for the coronavirus.The company is also…
The FDA needs to better communicate with state and local officials to improve food safety efforts, according to testimony heard by a House of Representatives subcommittee. Steven Mandernach, executive director of the Association of Food and Drug Officials (AFDO), on Wednesday delivered the testimony before the U.S. House of Representatives Committee on Energy and Commerce
Pros Wicks away moisture 360° arch support Made with an active grip for locked-in feel Comes in a pack of five I’ve tried many no-show socks, but this nylon-elastane blend from Lululemon exceeded my expectations during work, workouts, and everything in between. It fits like a glove, hugging the shape of my foot, and stays
Published: April 28, 2026, 8:36 pm Ghirardelli has recalled certain powdered beverage mixes. The recall was initiated following a recall initiated by California Dairies Inc. because of a concern of potential Salmonella contamination in milk powder, which was supplied to a third-party manufacturer and used as an ingredient in powdered beverage mixes. Neither Ghirardelli, its